Table 3.
Post-hoc comparisons across Facilities 2, 5 and 6 that share significantly different RUCA code and neighborhood contexts. Average consumption/occurrence levels across time are listed in column 3 to 5, and significant levels (p-values) for pair-wise between facility comparisons are listed in column 6 to 8.
| p-values for post-hoc two-sample t-test | ||||||||
|---|---|---|---|---|---|---|---|---|
| Average consumption/occurrences | Facilities with significant ADI difference | Facilities with RUCA differences | ||||||
| PPCP/HRS | Category | Facility 2 | Facility 5 | Facility 6 | Facility 2 vs. Facility 5 | Facility 2 vs. Facility 6 | Facility 5 vs. Facility 6 | |
| Acetaminophen | PPCP | OTC Pain Reliever | 44.02±12.4 | 24.47±9.13 | 52.49±16.19 | 4.00E-08 | 3.92E-02 | 5.10E-10 |
| Ibuprofen | PPCP | NSAID | 7.28±2.76 | 5.94±1.01 | 8.69±2.58 | 2.42E-02 | 5.99E-06 | |
| Naproxen | PPCP | NSAID | 4.5±1.37 | 4.44±0.69 | 6.44±1.41 | 6.75E-06 | 3.98E-08 | |
| Atenolol | PPCP | Licit Drug | 0.6±0.19 | 0.32±0.05 | 0.34±0.22 | 2.54E-09 | 4.38E-05 | |
| Carbamazepine | PPCP | Licit Drug | 0.02±0.01 | 0.03±0.01 | 0.04±0.06 | 4.20E-04 | ||
| Gemfibrozil | PPCP | Licit Drug | 0.39±0.08 | 0.28±0.11 | 0.47±0.56 | 1.33E-04 | ||
| Meprobamate | PPCP | Licit drug | 0.05±0.01 | 0.04±0.01 | 0.09±0.08 | 3.51E-06 | 1.26E-02 | 1.87E-03 |
| Primidone | PPCP | Licit Drug | 0.08±0.05 | 0.06±0.03 | 0.11 ±0.15 | 4.46E-02 | ||
| Sulfamethoxazole | PPCP | Licit Drug | ||||||
| Trimethoprim | PPCP | Licit Drug | ||||||
| Fluoxetine | PPCP | Licit Drug | ||||||
| Caffeine | PPCP | Daily | 29.36±6.5 | 21.68±3.83 | 40.68±40.81 | 3.83E-06 | 2.21E-02 | |
| DEET | PPCP | Daily | 0.1±0.08 | 0.27±0.15 | 0.07±0.13 | 2.34E-06 | 4.09E-06 | |
| Sucralose | PPCP | Daily | ||||||
| TCEP | PPCP | Daily | ||||||
| Triclosan | PPCP | Daily | ||||||
| Acetylmorphine | HRS | Opioid | 0±0.01 | 0.01±0.01 | 0.01±0.01 | 6.87E-03 | ||
| Codeine | HRS | Opioid | 0.04±0.01 | 0.05±0 | 0.05±0.04 | 6.70E-05 | 5.26E-02 | |
| EDDP | HRS | Opioid | 0.02±0 | 0.04±0 | 0.06±0.03 | 3.37E-17 | 9.49E-08 | 8.86E-04 |
| Hydrocodone | HRS | Opioid | 0.04±0.01 | 0.05±0.01 | 0.06±0.03 | 9.84E-06 | 8.27E-04 | 3.31E-02 |
| MDMA | HRS | Opiod | ||||||
| Methadone | HRS | Opioid | 0±0 | 0.01±0.01 | 0.02±0.01 | 1.12E-08 | 7.56E-22 | 6.85E-05 |
| Morphine | HRS | Opioid | 0.13±0.02 | 0.21±0.01 | 0.37±0.3 | 2.18E-20 | 1.99E-04 | 9.61 E-03 |
| Norfentanyl | HRS | Opioid | 0±0 | 0.01±0.01 | 0.01±0.02 | 2.14E-05 | 1.03E-02 | |
| Oxycodone | HRS | Opioid | 0.04±0.01 | 0.04±0.01 | 0.05±0.02 | 6.23E-04 | 3.06E-04 | 5.17E-02 |
| Tramadol | HRS | Opioid | 0.13±0.02 | 0.14±0.01 | 0.2±0.06 | 1.56E-03 | 7.37E-07 | 1.93E-05 |
| Amphetamine | HRS | Stimulant | 0.11 ±0.01 | 0.15±0.02 | 0.2±0.04 | 1.18E-13 | 4.22E-15 | 1.80E-07 |
| Benzoylecgonine | HRS | Simulant | 0.32±0.05 | 0.76±0.12 | 0.25±0.26 | 5.70E-23 | 2.73E-12 | |
| Cocaine | HRS | Stimulant | 0.14±0.06 | 0.34±0.09 | 0.05±0.04 | 4.37E-13 | 1.72E-08 | 1.45E-20 |
| Ecgonine | HRS | Stimulant | 0.04±0.01 | 0.12±0.02 | 0.03±0.04 | 4.79E-22 | 3.82E-13 | |
| Ecgonine methyl ester | HRS | Stimulant | 0.1±0.02 | 0.25±0.06 | 0.06±0.06 | 7.62E-16 | 2.27E-03 | 1.50E-15 |
| Methamphetamine | HRS | Stimulant | 0.38±0.09 | 1.79±0.23 | 1.34±0.35 | 4.23E-33 | 1.45E-18 | 1.21E-06 |
| THC-COOH | HRS | Marijuana | 0.53±0.14 | 0.77±0.09 | 0.97±0.33 | 1.74E-09 | 8.41 E-08 | 4.18E-03 |
| THC-OH | HRS | Marijuana | 0.06±0.11 | 0.12±0.16 | 0.26±0.13 | 1.15E-07 | 8.34E-04 | |